Serina Therapeutics (SER) Retained Earnings (2017 - 2026)
Serina Therapeutics (SER) posted Retained Earnings of -$63.5 million for Q4 2025, down 1587400.0% sequentially from -$4000.0 in Q3 2025, and down 43.28% YoY from -$112.0 million in Q4 2024.
Serina Therapeutics (SER) Retained Earnings (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Retained Earnings for 9 years, with the latest figure at -$63.5 million in Q4 2025.
- Quarterly Retained Earnings fell 43.28% year-over-year to -$63.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$63.5 million (down 43.28% YoY) and the FY2025 annual result came in at -$63.5 million, down 43.28% from the prior year.
- Retained Earnings retreated to -$63.5 million in Q4 2025 per SER's latest filing, from -$4000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $100.0 million in Q3 2023 and troughed at -$122.2 million in Q2 2023.
- A 5-year average of -$51.5 million and a median of -$59.5 million in 2025 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2021 and 2025: Retained Earnings slumped 225465.91% in 2021, then surged 205.48% in 2025.
- Over 5 years, Retained Earnings stood at -$105.7 million in 2021, then surged by 193.62% to $99.0 million in 2022, then plunged by 99.11% to $883000.0 in 2023, then sank by 5119.03% to -$44.3 million in 2024, then slumped by 43.28% to -$63.5 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered -$63.5 million, -$4000.0, and -$55.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | 4.38 Bn |
| 10 | Serina Therapeutics | 44.24 Mn | 21.22 Mn | - | 95.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 95.48 Mn |
| Dec 31, 2025 | -63.50 Mn |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -55.58 Mn |
| Mar 31, 2025 | 50.83 Mn |
| Dec 31, 2024 | -44.32 Mn |
| Sep 30, 2024 | -41.58 Mn |
| Jun 30, 2024 | -42.99 Mn |
| Mar 31, 2024 | -48.19 Mn |
| Dec 31, 2023 | 883,000.00 |
| Sep 30, 2023 | 100.02 Mn |
| Jun 30, 2023 | -122.20 Mn |
| Mar 31, 2023 | -119.50 Mn |
| Dec 31, 2022 | 99.00 Mn |
| Sep 30, 2022 | -113.51 Mn |
| Jun 30, 2022 | -111.07 Mn |
| Mar 31, 2022 | -108.50 Mn |
| Dec 31, 2021 | -105.75 Mn |
| Sep 30, 2021 | -103.59 Mn |
| Jun 30, 2021 | -101.60 Mn |